Home » Panel’s Support May Help Case for Medtronic’s Amplify Matrix
Panel’s Support May Help Case for Medtronic’s Amplify Matrix
Medtronic may have picked up some support for approval of its Amplify recombinant human bone morphogenetic protein-2 (rhBMP) matrix when a Centers for Medicare & Medicaid Services’ (CMS) panel voiced confidence in current on-label uses for rhBMPs. CMS’ Medicare Evidence Development & Coverage Advisory Committee met recently to weigh the evidence and benefits of approved and off-label uses of rhBMPs. Use of the proteins has grown rapidly since they became clinically available in 2001. However, up to 85 percent of that use is off-label, mostly in the spine, CMS says.
Devices & Diagnostics Letter
Devices & Diagnostics Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May